News

Can Newly Approved “Tissue Agnostic” Drugs Benefit Pediatric High-grade Glioma Patients? Recently, the U.S. Food and Drug Administration (FDA) granted accelerated approval* to the drug Rozlytrek (entrectinib, Genentech/Roche**) as a treatment for patients, 12 years or older, whose tumors have a specific genetic defect known as an “NTRK gene fusion.”*** This is now the second drug that the FDA has approved to treat patients with this […] September 16, 2019

A Missing Link to Glioblastoma Growth? An enzyme that serves as a link between oncogenes and the lipids that make-up cells’ membranes may be an important new drug target to treat glioblastoma and other tumors Glioblastoma, like all cancers, develops and progresses as cells begin to multiply and grow out of control, forming a tumor.  Mutations to a protein known as […] August 6, 2019

Gliogene: Confronting the Unknown Through Research As the saying goes, knowledge is power. But, sometimes, it can also be scary. “Oh, it’s horrible!” says Carrie Davis about her quest, which she shares with her sister Hadley, to help better understand links between inheritable genes and brain tumors. She continues, “Every time I get a headache I think I have a brain […] July 23, 2019

Brain Tumor Patients Inspire Research Toward Better Treatment Patients are major motivators for physician-scientist Dr. Elizabeth B. Claus. They and their caregivers share their lives with her, get her up to speed on their favorite Boston sports teams, and, at the same time, ask the important questions that help generate new research ideas. Dr. Claus’s research focuses on cancer and genetic epidemiology, with […] July 1, 2019

Bay Area Brain Tumor Walk & UCSF: Celebrating 25 Years of Collaboration Last July, the National Brain Tumor Society marked the 10-year anniversary of the 2008 merger that brought together its legacy organizations — The Brain Tumor Society (TBTS) and the National Brain Tumor Foundation (NBTF) — and created NBTS as it stands today. And on Sunday, June 23, 2019, at Crissy Field in San Francisco, NBTS […] June 6, 2019